BRPI0910691A2 - compostos e composições como inibidores de itpkb - Google Patents
compostos e composições como inibidores de itpkbInfo
- Publication number
- BRPI0910691A2 BRPI0910691A2 BRPI0910691A BRPI0910691A BRPI0910691A2 BR PI0910691 A2 BRPI0910691 A2 BR PI0910691A2 BR PI0910691 A BRPI0910691 A BR PI0910691A BR PI0910691 A BRPI0910691 A BR PI0910691A BR PI0910691 A2 BRPI0910691 A2 BR PI0910691A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- compounds
- itpkb
- inhibitors
- itpkb inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4236908P | 2008-04-04 | 2008-04-04 | |
| PCT/US2009/038734 WO2009123948A2 (en) | 2008-04-04 | 2009-03-30 | Compounds and compositions as itpkb inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0910691A2 true BRPI0910691A2 (pt) | 2018-03-27 |
Family
ID=40670049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0910691A BRPI0910691A2 (pt) | 2008-04-04 | 2009-03-30 | compostos e composições como inibidores de itpkb |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110263610A1 (pt) |
| EP (1) | EP2274302A2 (pt) |
| JP (1) | JP2011516485A (pt) |
| KR (1) | KR20100137557A (pt) |
| CN (1) | CN102083817A (pt) |
| AU (1) | AU2009231953A1 (pt) |
| BR (1) | BRPI0910691A2 (pt) |
| CA (1) | CA2720490A1 (pt) |
| EA (1) | EA201001586A1 (pt) |
| MX (1) | MX2010010877A (pt) |
| WO (1) | WO2009123948A2 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201121794D0 (en) * | 2011-12-19 | 2012-02-01 | Isis Innovation | PIM kinase inhibitors |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| EP3607941A1 (en) | 2013-04-30 | 2020-02-12 | Otitopic Inc. | Dry powder formulations and methods of use |
| CN104829592B (zh) * | 2015-05-22 | 2017-03-15 | 河南科技大学第一附属医院 | 4‑哌啶基‑1h‑吡咯‑3‑甲酰胺类化合物盐酸盐的合成方法 |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| EP3684338A4 (en) | 2017-09-22 | 2021-06-23 | Otitopic Inc. | DRY POWDER COMPOSITIONS CONTAINING MAGNESIUM STEARATE |
| MX2020005818A (es) * | 2017-12-19 | 2020-08-20 | Bristol Myers Squibb Co | Triazol azoles de acido ciclohexilo como antagonistas de acido lisofosfatidico (lpa). |
| CN113549054B (zh) * | 2020-04-23 | 2024-03-15 | 鲁南制药集团股份有限公司 | 一种富马酸沃诺拉赞中间体及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3810017B2 (ja) * | 2000-04-27 | 2006-08-16 | アステラス製薬株式会社 | 縮合ヘテロアリール誘導体 |
| WO2008004100A2 (en) * | 2006-07-05 | 2008-01-10 | Pfizer Products Inc. | Therapeutic compounds |
| TW200817375A (en) * | 2006-07-21 | 2008-04-16 | Irm Llc | Compounds and compositions as ITPKB inhibitors |
| EA200901656A1 (ru) * | 2007-06-15 | 2010-06-30 | Айрм Ллк | СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ ITPKb |
-
2009
- 2009-03-30 EP EP09727043A patent/EP2274302A2/en not_active Withdrawn
- 2009-03-30 BR BRPI0910691A patent/BRPI0910691A2/pt not_active IP Right Cessation
- 2009-03-30 CA CA2720490A patent/CA2720490A1/en not_active Abandoned
- 2009-03-30 EA EA201001586A patent/EA201001586A1/ru unknown
- 2009-03-30 JP JP2011503065A patent/JP2011516485A/ja active Pending
- 2009-03-30 CN CN2009801209242A patent/CN102083817A/zh active Pending
- 2009-03-30 US US12/935,273 patent/US20110263610A1/en not_active Abandoned
- 2009-03-30 KR KR1020107024737A patent/KR20100137557A/ko not_active Application Discontinuation
- 2009-03-30 MX MX2010010877A patent/MX2010010877A/es not_active Application Discontinuation
- 2009-03-30 WO PCT/US2009/038734 patent/WO2009123948A2/en active Application Filing
- 2009-03-30 AU AU2009231953A patent/AU2009231953A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2274302A2 (en) | 2011-01-19 |
| WO2009123948A2 (en) | 2009-10-08 |
| US20110263610A1 (en) | 2011-10-27 |
| EA201001586A1 (ru) | 2011-06-30 |
| MX2010010877A (es) | 2010-10-26 |
| CA2720490A1 (en) | 2009-10-08 |
| AU2009231953A1 (en) | 2009-10-08 |
| JP2011516485A (ja) | 2011-05-26 |
| CN102083817A (zh) | 2011-06-01 |
| KR20100137557A (ko) | 2010-12-30 |
| WO2009123948A3 (en) | 2009-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0912668A2 (pt) | composto e composições como inibidores de quinase | |
| SMT201600307B (it) | Composizione liposomiale | |
| BRPI0914652A2 (pt) | compostos e composições como inibidores de quinase | |
| BRPI0906749A2 (pt) | Composição | |
| DK2634232T3 (da) | Sammensætninger | |
| BRPI0913808A2 (pt) | composição | |
| BRPI0911228A2 (pt) | compostos e composições como inibidores de proteínas quinase | |
| BRPI0906973A2 (pt) | Compostos e composições como inibidores de cinase. | |
| BRPI1013588A2 (pt) | composição | |
| DK3078664T3 (da) | Antiparasitiske dihydroazol-sammensætninger | |
| DE602008002756D1 (de) | Bauzusammensetzung | |
| BRPI0908849A2 (pt) | Composto e composições como c-kit e inibidores de pdgfr quinase | |
| IT1392101B1 (it) | Composizione comprendente isoflavoni | |
| BRPI1015474A2 (pt) | composição | |
| FR2941462B1 (fr) | Composition decapante | |
| BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
| UY33161A (es) | Composiciones plaguicidas | |
| BRPI0917231A2 (pt) | composição | |
| BRPI0913127A2 (pt) | composição de resfriamento | |
| BRPI0910979A2 (pt) | compostos e composições como inibidores de quinase | |
| DOP2011000396A (es) | Composiciones novedosas | |
| BRPI0914545A2 (pt) | compostos e composições como inibidores de quinase | |
| DK2403814T3 (da) | Landbrugsmæssig sammensætning | |
| BRPI1010690A2 (pt) | composições | |
| BRPI0920287A2 (pt) | composição para lavagem de louças |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |